menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Evidence' ×
Alison Bourke
QuintilesIMS Research Forum showcases groundbreaking studies using RWD that are aiding public policy decisions and treatment protocols.
Read More
Randy Thomas
Exploring the IT infrastructure healthcare organizations will need to support their move to Advanced APMs.
Read More
Adina Knight
At this year’s DIA annual meeting, Adina Knight will share insights into the effective use of big data in combination with patient and physician feedback to streamline recruiting for rare disease trials.
Read More
Allen Kindman
Mike Montello
Siteless trials and virtual doctor visits are just a few of the tantalizing tools that will redefine the next generation of clinical research.
Read More
NancyDreyer
Don’t miss this DIA panel where FDA and EMA leaders will discuss when and where real-world evidence could replace RCTs.
Read More
Big data and rare disease research take center stage of this year’s BIO International in June.
Read More
Brad Smith
John Doyle
Expectations for RWE are shaping the value conversation in healthcare. At this year’s ISPOR, we will explore what this trend means for pharma and how they can generate the most benefit from these studies.
Read More
NancyDreyer
How pragmatic clinical trials (PCTs) increase the robustness of real world studies at a fraction of the cost of classical randomized controlled clinical trials (RCTs).
Read More